Joseph J Wolk Johnson & Johnson (JNJ) insider trading activity

Joseph J Wolk is Exec VP, CFO of JOHNSON & JOHNSON. Currently has a direct ownership of 5,345 shares of JNJ, which is worth approximately $867,493. The most recent transaction as insider was on Feb 18, 2025, when has been sold 768 shares (Common Stock) at a price of $156.15 per share, resulting in proceeds of $119,923. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.35K

Infinity% 3M change

92.24% 12M change

Total Value Held $867,493

Joseph J Wolk Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 18 2025	SELL Payment of exercise price or tax liability	$119,923 $156.15 p/Share	768 Reduced 12.56%	5,345 Common Stock
Feb 15 2025	BUY Exercise of conversion of derivative security	-	1,971 Added 24.38%	6,113 Common Stock
Feb 14 2025	SELL Payment of exercise price or tax liability	$1,298,583 $156.23 p/Share	8,312 Reduced 37.25%	14,000 Common Stock
Feb 14 2025	BUY Exercise of conversion of derivative security	-	19,330 Added 48.34%	20,661 Common Stock
Feb 13 2025	BUY Exercise of conversion of derivative security	-	1,779 Added 50.0%	1,779 Common Stock
Feb 07 2025	SELL Open market or private sale	$2,002,878 $153.89 p/Share	13,015 Reduced 100.0%	0 Common Stock
Feb 07 2025	BUY Exercise of conversion of derivative security	$1,302,280 $100.06 p/Share	13,015 Added 50.0%	13,015 Common Stock
Oct 17 2024	SELL Bona fide gift	-	68,835 Reduced 100.0%	0 Common Stock
May 22 2024	SELL Bona fide gift	-	55 Reduced 0.08%	68,835 Common Stock
Feb 13 2024	SELL Payment of exercise price or tax liability	$122,018 $157.85 p/Share	773 Reduced 1.11%	68,890 Common Stock
Feb 13 2024	BUY Exercise of conversion of derivative security	-	1,780 Added 2.49%	69,663 Common Stock
Feb 12 2024	SELL Payment of exercise price or tax liability	$1,702,438 $157.4 p/Share	10,816 Reduced 13.74%	67,883 Common Stock
Feb 12 2024	BUY Exercise of conversion of derivative security	-	25,835 Added 24.71%	78,699 Common Stock
Feb 08 2024	SELL Payment of exercise price or tax liability	$163,677 $156.33 p/Share	1,047 Reduced 1.94%	52,864 Common Stock
Feb 08 2024	BUY Exercise of conversion of derivative security	-	3,686 Added 6.4%	53,911 Common Stock
Aug 23 2023	SELL Sale (or disposition) back to the issuer	-	67 Reduced 0.13%	50,275 Common Stock
May 24 2023	SELL Bona fide gift	-	55 Reduced 0.11%	50,342 Common Stock
Feb 13 2023	SELL Payment of exercise price or tax liability	$1,389,721 $162.01 p/Share	8,578 Reduced 14.55%	50,397 Common Stock
Feb 13 2023	BUY Grant, award, or other acquisition	-	20,693 Added 25.97%	58,975 Common Stock
Feb 10 2023	SELL Payment of exercise price or tax liability	$158,676 $162.08 p/Share	979 Reduced 2.49%	38,282 Common Stock
Feb 10 2023	BUY Exercise of conversion of derivative security	-	3,449 Added 8.08%	39,261 Common Stock
Dec 13 2022	SELL Open market or private sale	$2,653,780 $179.54 p/Share	14,781 Reduced 29.22%	35,812 Common Stock
Dec 13 2022	BUY Exercise of conversion of derivative security	$1,204,503 $81.49 p/Share	14,781 Added 22.61%	50,593 Common Stock
Apr 20 2022	SELL Bona fide gift	-	46 Reduced 0.13%	35,812 Common Stock
Feb 15 2022	SELL Payment of exercise price or tax liability	$1,214,149 $165.89 p/Share	7,319 Reduced 16.95%	35,858 Common Stock

Also insider at

KVUE

Kenvue Inc.

Director

JJW

Joseph J Wolk

Exec VP, CFO

New Brunswick, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JNJ shares.

Notify only if

Value

Insider Trading

Get notified when an Johnson & Johnson insider buys or sells JNJ shares.

Notify only if

Operation

Value

Type

News

Receive news related to JOHNSON & JOHNSON

Track Activities on JNJ

Account